Abeona Therapeutics Inc

Abeona Therapeutics Inc Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated cell and gene therapy company. Abeona Therapeutics Inc.

(Nasdaq: ABEO) is a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare genetic diseases

Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases.

Together with patients, families, caregivers and advocates, Abeona team members participated in DASH4DEBRA in support of...
08/27/2026

Together with patients, families, caregivers and advocates, Abeona team members participated in DASH4DEBRA in support of the epidermolysis bullosa (EB) community.

Thank you to debra of America for bringing people together to raise awareness and support for those affected by EB.

We were thrilled to be on site at the 2026 debra of America Care Conference in Los Angeles! This incredible gathering br...
07/30/2026

We were thrilled to be on site at the 2026 debra of America Care Conference in Los Angeles!

This incredible gathering brought together individuals and families living with epidermolysis bullosa (EB) alongside clinicians and researchers, all united in advancing care, support and innovation for the EB community.

Caring for someone with an ultra-rare condition like recessive dystrophic epidermolysis bullosa ( ) comes with daily cha...
06/19/2026

Caring for someone with an ultra-rare condition like recessive dystrophic epidermolysis bullosa ( ) comes with daily challenges. In this BioSpace Denatured episode, Abeona CEO & Director Vishwas Seshadri shares how new gene and cell therapies could help change what’s possible for patients and families.

Listen here:

In this episode of Denatured, you’ll hear from Mark Lowdell, CSO & co-founder at INmuneBio Inc. and Vishwas Seshadri, CEO & director at Abeona Therapeutics. We explore how recessive dystrophic epidermolysis bullosa has become a defining case study for gene and cell therapy and what this ultra‑ra...

We were so excited to jump back in and Plunge for Elodie this year! On April 8, our Cleveland team hosted a dunk tank to...
04/17/2026

We were so excited to jump back in and Plunge for Elodie this year! On April 8, our Cleveland team hosted a dunk tank to support EB Research Partnership and the amazing epidermolysis bullosa (EB) community.

Address

1330 6th Avenue
Manhattan, NY
10019

Website

Alerts

Be the first to know and let us send you an email when Abeona Therapeutics Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category